Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-01 Fairmount Funds Management LLC Director Conversion +3,553,410 4,685,364
2026-07-01 Fairmount Funds Management LLC Director Sale −3,553,410 $84.43 $300.0M 1,131,954
2026-07-01 Fairmount Funds Management LLC Director Conversion · Series B Preferred Stock −42,641 94,497
2026-06-02 Fairmount Funds Management LLC Director Grant or award · Stock Option (Right to Buy) +9,136 9,136
2025-09-17 Fairmount Funds Management LLC Director Grant or award +333,340 $15.00 $5.0M 1,131,954
2025-06-02 Fairmount Funds Management LLC Director Grant or award · Stock Option (Right to Buy) +17,500 17,500
2024-11-19 Fairmount Funds Management LLC Director Option exercise +160,000 798,614
2024-11-19 Fairmount Funds Management LLC Director Option exercise · Series A Non-Voting Convertible Preferred Stock −160 0
2024-09-11 Fairmount Funds Management LLC Director Grant or award +275,000 $23.00 $6.3M 638,614
2024-09-11 Fairmount Funds Management LLC Director Grant or award · Series A Non-Voting Convertible Preferred Stock +160 $23,000.00 $3.7M 160

Page 1 of 1 · 10 trades